日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance

肝脏 FoxO1、PGC-1α 和 SREBP-1c 的协调调节促进胰岛素作用和抵抗

Mini P Sajan, Mackenzie C Lee, Fabienne Foufelle, Joshua Sajan, Courtney Cleland, Robert V Farese

Atypical PKC, PKCλ/ι, activates β-secretase and increases Aβ1-40/42 and phospho-tau in mouse brain and isolated neuronal cells, and may link hyperinsulinemia and other aPKC activators to development of pathological and memory abnormalities in Alzheimer's disease

非典型 PKC,PKCλ/ι,可激活 β-分泌酶并增加小鼠大脑和分离的神经元细胞中的 Aβ1-40/42 和磷酸化 tau,并可能将高胰岛素血症和其他 aPKC 激活剂与阿尔茨海默病的病理和记忆异常的发展联系起来

Mini P Sajan, Barbara C Hansen, Margaret G Higgs, C Ron Kahn, Ursula Braun, Michael Leitges, Collin R Park, David M Diamond, Robert V Farese

Compensation for PKMζ in long-term potentiation and spatial long-term memory in mutant mice

突变小鼠长期增强和空间长期记忆中 PKMζ 的补偿

Panayiotis Tsokas, Changchi Hsieh, Yudong Yao, Edith Lesburguères, Emma Jane Claire Wallace, Andrew Tcherepanov, Desingarao Jothianandan, Benjamin Rush Hartley, Ling Pan, Bruno Rivard, Robert V Farese, Mini P Sajan, Peter John Bergold, Alejandro Iván Hernández, James E Cottrell, Harel Z Shouval, And

BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans

肥胖和 2 型糖尿病患者肝脏中通过 IRS-1、Akt、FoxO1 和 PGC-1α 发生的胰岛素信号传导中与 BMI 相关的非典型 PKC 依赖性异常进展

Mini P Sajan, Robert A Ivey 3rd, Robert V Farese

Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation

ob/ob 小鼠的肝脏胰岛素抵抗与神经酰胺、aPKC 活性增加以及 Akt 依赖性 FoxO1 磷酸化的选择性损伤有关

Mini P Sajan, Robert A Ivey, Mackenzie C Lee, Robert V Farese

Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity

肝脏 FoxO1 的 Akt 依赖性磷酸化在 WD40/ProF 支架上被区室化,并在饮食诱导性肥胖的早期阶段被 aPKC 选择性抑制

Mini P Sajan, Mildred E Acevedo-Duncan, Mary L Standaert, Robert A Ivey, Mackenzie Lee, Robert V Farese

PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes

PKCλ 单倍体不足通过改变肝酶的机制来预防糖尿病

Mini P Sajan, Robert A Ivey 3rd, Mackenzie Lee, Stephen Mastorides, Michael J Jurczak, Varman T Samuels, Gerald I Shulman, Ursula Braun, Michael Leitges, Robert V Farese

Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι

肝蛋白激酶 C-ι 抑制剂可纠正肥胖、代谢综合征和 2 型糖尿病啮齿动物模型中的代谢异常

Mini P Sajan, Sonali Nimal, Stephen Mastorides, Mildred Acevedo-Duncan, C Ronald Kahn, Alan P Fields, Ursula Braun, Michael Leitges, Robert V Farese

Mechanisms for increased insulin-stimulated Akt phosphorylation and glucose uptake in fast- and slow-twitch skeletal muscles of calorie-restricted rats

热量限制大鼠快肌和慢肌骨骼肌中胰岛素刺激 Akt 磷酸化和葡萄糖摄取增加的机制

Naveen Sharma, Edward B Arias, Abhijit D Bhat, Donel A Sequea, Steve Ho, Kelsey K Croff, Mini P Sajan, Robert V Farese, Gregory D Cartee

Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation

磷脂酰肌醇 3-激酶 p110alpha 异构体在肝脏胰岛素信号传导和代谢调节中的特殊作用

Victoria Rotter Sopasakis, Pixu Liu, Ryo Suzuki, Tatsuya Kondo, Jonathon Winnay, Thien T Tran, Tomoichiro Asano, Graham Smyth, Mini P Sajan, Robert V Farese, C Ronald Kahn, Jean J Zhao